Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Anthropic details drug R&D ambitions, risks in IPO filing

The AI giant behind Claude is gearing up for a blockbuster IPO as it expands into drug discovery with its own molecular biology lab.

Michael Gibney Oct 26, 2026 11:44am

Lycia leaps onto Nasdaq with $318M IPO as Windward eyes debut

Oct 26, 2026 10:00am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

ESMO: Incyte claims ‘neck and neck’ KRAS G12D race with RevMed

Oct 26, 2026 9:45am

Biotech value creation at an inflection point

Brought to you by Lumanity

BioNTech sees limited ADC benefit as ph. 3 shows modest efficacy

Oct 26, 2026 8:39am